🟢 Hims & Hers Health is trading 3.78% up as investors reassess FTC lawsuit allegations

Hims & Hers Health is trading at €26.88, up +3.78% as investors reassess the FTC lawsuit allegations.

• Shares continued recovering from the July 29 FTC lawsuit-driven selloff.
• The rebound was also supported by the company’s new AI-native Hers app launch and anticipation of second-quarter results due after the August 10 market close.
• Broader sentiment was mildly constructive, but no major index move occurred during the August 7 session.